HIV and viral hepatitis coinfections: advances and challenges.
about
The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban settingSpotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis CEarly-life exposures to infectious agents and later cancer developmentNew agents for the treatment of hepatitis C in patients co-infected with HIVCCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug usersDetection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected IndividualsInfection of female primary lower genital tract epithelial cells after natural pseudotyping of HIV-1: possible implications for sexual transmission of HIV-1.Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in EthiopiaPros and cons of liver transplantation in human immunodeficiency virus infected recipients.HIV and HCV coinfection: prevalence, associated factors and genotype characterization in the Midwest Region of Brazil.Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated populationHIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.Management of chronic hepatitis B in patients from special populationsHIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary CareHepatitis C treatment initiation in HIV-HCV coinfected patients.High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiSero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia.Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.Different faces of hepatocellular carcinoma as a health threat in 21st centuryViral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients.Primary care of women aging with HIV.Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.Treatment of Hepatitis B: A Concise Review.Update on HIV/HCV coinfection.Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.Future considerations for dendritic cell immunotherapy against chronic viral infections.Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.Cross-Sectional Study to Determine the Prevalence of Hepatitis B and C Virus Infection in High Risk Groups in the Northeast Region of Brazil.Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.Prevalence and Determinants of Cryptosporidium Infection in an Underdeveloped Rural Region of Southwestern China.Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.Performance of ANTI-HCV testing in dried blood spots and saliva according to HIV status.Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.
P2860
Q21559628-F16EDF3B-B3EC-476F-BC61-D347363A6EA3Q26740233-B3765327-C05F-404D-8C17-64496F7A3A26Q26786103-1AFA1095-6272-4A89-B144-DA4F598FAA92Q27006027-B3F2D086-29F9-4481-9567-220775FC4B7BQ28534869-E69FD143-1388-434B-9280-6D354CB05034Q28548313-BAF9D9D9-85A3-44BF-83E3-20D967F96EDCQ30364549-5FF98B87-D684-4878-9666-0E0209089D84Q30382346-6CA80111-9581-497A-B83C-EBB86361F2FFQ33594879-7FAE104B-5390-47F0-A70A-58E0E6CC6933Q34977282-7C2798FF-E25A-4D41-9DCF-34FEEC542D78Q34981656-937ADB78-2432-447C-B2E2-276C8F34AAFDQ35033499-6E9B8056-8061-4802-BD09-1078FDD375C9Q35042619-28A5B0FE-0B03-4525-B429-87E58632EA44Q35664183-B9A29637-45DD-492D-BFB3-4640C874484CQ36015496-D1FF8D89-23D0-4796-AC60-08DF6D953263Q36083688-EBBFD5D5-EDB1-4215-9604-E84B397FAE6FQ36268801-6E024353-2482-4CFE-87AB-0AB3E3E88B6DQ36293979-DF593988-5895-42C1-84AB-FF71F15C992BQ36550395-EF91A5D8-01C4-4112-AA9F-896CF3040FBBQ36698116-781F597A-501F-41F5-89A7-D5139C6A3D24Q36732492-B8E64158-FD6E-4CF8-B14D-5C909320A45AQ36783264-55C01177-503D-4132-B35B-998F475CE642Q36821936-2DEAC9F6-C2EA-4B7E-83D1-96CB5BEA027AQ37111444-E1E84D0E-3C29-4F81-BCB9-42FD70ACF702Q37272968-44763373-002A-49D8-8B8A-8FD507F8B143Q37415420-015ED9AE-22CD-4C91-A6D3-93C20615D6B9Q37620340-0B4ED8E0-8120-406D-8D57-113EB93D4475Q38119893-B0CFA2FC-8A4B-479A-8C0E-BA4995E28730Q38203823-6FC8A1FF-598E-4E0E-80F9-51FC69D59329Q38204769-56B87AF6-4F18-4A59-904F-8343133692EDQ38295822-788037BC-1A65-4AEC-B8BB-57C541CC0243Q38675898-5E029DD9-8D24-4CD9-B7C4-8F9A983B8923Q38918596-CE53F75F-3F44-4CCA-9C47-55A2123E35D8Q39037936-15463497-C851-4960-84E5-24AC1B0A41C6Q39491769-BA5CE7BA-F3FA-4248-A23E-C91E62606DBFQ39503010-C9FA7191-4851-423A-A9F5-90D57EEFDAB5Q39613730-36368F75-9DC8-45B4-A70B-5798E58B4351Q40040535-9AE4A7F8-2401-490D-A036-76D1843C3202Q40343820-D893EF43-C619-4959-A87B-E6D65F6E438EQ40590338-4F667E17-2B76-48E6-A744-42B41FF75BB6
P2860
HIV and viral hepatitis coinfections: advances and challenges.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HIV and viral hepatitis coinfections: advances and challenges.
@en
type
label
HIV and viral hepatitis coinfections: advances and challenges.
@en
prefLabel
HIV and viral hepatitis coinfections: advances and challenges.
@en
P1433
P1476
HIV and viral hepatitis coinfections: advances and challenges.
@en
P2093
Juergen Rockstroh
Karine Lacombe
P304
P356
10.1136/GUTJNL-2012-302062
P407
P478
61 Suppl 1
P577
2012-05-01T00:00:00Z